These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38245998)

  • 1. Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines.
    Yamout B; Al-Jumah M; Sahraian MA; Almalik Y; Khaburi JA; Shalaby N; Aljarallah S; Bohlega S; Dahdaleh M; Almahdawi A; Khoury SJ; Koussa S; Slassi E; Daoudi S; Aref H; Mrabet S; Zeineddine M; Zakaria M; Inshasi J; Gouider R; Alroughani R
    Mult Scler Relat Disord; 2024 Mar; 83():105435. PubMed ID: 38245998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS).
    Yamout B; Alroughani R; Al-Jumah M; Goueider R; Dahdaleh M; Inshasi J; Hashem S; Alsharoqi I; Sahraian M; Khoury S; Alkawi Z; Koussa S; Zakaria M; Al Khaburi J; Alsaadi T; Bohlega S
    Curr Med Res Opin; 2015; 31(7):1349-61. PubMed ID: 25946578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines.
    Yamout B; Sahraian M; Bohlega S; Al-Jumah M; Goueider R; Dahdaleh M; Inshasi J; Hashem S; Alsharoqi I; Khoury S; Alkhawajah M; Koussa S; Al Khaburi J; Almahdawi A; Alsaadi T; Slassi E; Daodi S; Zakaria M; Alroughani R
    Mult Scler Relat Disord; 2020 Jan; 37():101459. PubMed ID: 31670208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of diagnostic and treatment practices for multiple sclerosis in Europe.
    Fernández O; Delvecchio M; Edan G; Fredrikson S; Gionvannoni G; Hartung HP; Havrdova E; Kappos L; Pozzilli C; Soerensen PS; Tackenberg B; Vermersch P; Comi G
    Eur J Neurol; 2017 Mar; 24(3):516-522. PubMed ID: 28139062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
    Sorensen PS; Sellebjerg F; Hartung HP; Montalban X; Comi G; Tintoré M
    Brain; 2020 Sep; 143(9):2637-2652. PubMed ID: 32710096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early accurate diagnosis crucial in multiple sclerosis.
    Tur C; Thompson AJ
    Practitioner; 2015 Sep; 259(1785):21-7, 2-3. PubMed ID: 26591653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Sclerosis: An Emergency Medicine-Focused Narrative Review.
    Pelletier J; Sugar D; Koyfman A; Long B
    J Emerg Med; 2024 Apr; 66(4):e441-e456. PubMed ID: 38472027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for diagnosis and management of multiple sclerosis.
    Kes VB; Zavoreo I; Serić V; Solter VV; Cesarik M; Hajnsek S; Pasić MB; Gabelić T; Silvio B; Butković SS; Lusić I; Grbelja LD; Vladić A; Bielen I; Antoncić I; Demarin V; ; ;
    Acta Clin Croat; 2012 Mar; 51(1):117-35. PubMed ID: 22920014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from SPECTRUM: A survey of healthcare professionals to understand current diagnosis and management practices for secondary progressive multiple sclerosis in the United Kingdom.
    Duddy M; Wilkinson C; Medhurst S; Rhys K
    Mult Scler Relat Disord; 2021 Oct; 55():103174. PubMed ID: 34399317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discussing the potential for progression with patients newly diagnosed with multiple sclerosis: When, how, and why?
    Shosha E; Burton JM
    Mult Scler Relat Disord; 2022 Dec; 68():104230. PubMed ID: 36240704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification, diagnosis, and differential diagnosis of multiple sclerosis.
    Katz Sand I
    Curr Opin Neurol; 2015 Jun; 28(3):193-205. PubMed ID: 25887774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of suspected multiple sclerosis: a consensus approach.
    Miller DH; Weinshenker BG; Filippi M; Banwell BL; Cohen JA; Freedman MS; Galetta SL; Hutchinson M; Johnson RT; Kappos L; Kira J; Lublin FD; McFarland HF; Montalban X; Panitch H; Richert JR; Reingold SC; Polman CH
    Mult Scler; 2008 Nov; 14(9):1157-74. PubMed ID: 18805839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis.
    Stühler E; Braune S; Lionetto F; Heer Y; Jules E; Westermann C; Bergmann A; van Hövell P;
    BMC Med Res Methodol; 2020 Feb; 20(1):24. PubMed ID: 32028898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
    Kerbrat A; Hamonic S; Leray E; Tron I; Edan G; Yaouanq J;
    Eur J Neurol; 2015 Mar; 22(3):507-e35. PubMed ID: 25515927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing 'transition' to secondary progressive multiple sclerosis (SPMS): A step-by-step approach for clinicians.
    Hamdy E; Talaat F; Ramadan I; Marouf H; Hamdy MM; Sadallah H; El-Ashmawy GAH; Elsalamawy D; Said SM
    Mult Scler Relat Disord; 2022 Apr; 60():103718. PubMed ID: 35279626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis.
    Yun JW; Cvek U; Kilgore PCSR; Tsunoda I; Omura S; Sato F; Zivadinov R; Ramanathan M; Minagar A; Alexander JS
    Life Sci; 2019 Jul; 229():116-123. PubMed ID: 31082401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
    Foo EC; Russell M; Lily O; Ford HL
    Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.
    Boyko A; Therapontos C; Horakova D; Szilasiová J; Kalniņa J; Kolontareva J; Gross-Paju K; Selmaj K; Sereike I; Milo R; Gabelić T; Rot U
    Mult Scler Relat Disord; 2021 May; 50():102778. PubMed ID: 33592384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.